Table 1.
mean ± SD | |
---|---|
Clinical characteristics | |
Female (%) | 56% |
Caucasian (%) | 77% |
Age (y) | 34.3 ± 6.8 |
Body mass index (BMI) (kg/m2) | 35.8 ± 5.8 |
Physical activity (hrs/week) | 4.6 ± 5.2 |
Dual-energy x-ray absorptiometry | |
Appendicular lean mass (ALM) (kg) | 29.1 ± 7.4 |
% ideal appendicular lean mass (%) | 102.2 ± 9.5 |
Computed tomography | |
Visceral adipose tissue (cm2) (VAT) | 130.4 ± 62.7 |
Abdominal subcutaneous tissue (cm2) (SAT) | 461.6 ± 138.7 |
VAT/SAT | 0.29 ± 0.16 |
Thigh muscle area (cm2) | 5.2 ± 0.2 |
Thigh muscle density (HU) | 48.3 ± 4.9 |
Thigh intermuscular adipose tissue (IMAT) (cm2) | 8.8 ± 3.8 |
Magnetic resonance spectroscopy | |
Soleus intramyocellular lipids (lipid/water) | 0.04 ± 0.02 |
Intrahepatic lipids (lipid/water) | 0.15 ± 0.24 |
Glucose homeostasis | |
Matsuda Index | 5.7 ± 4.4 |
Impaired fasting glucose (%)* | 3% |
Impaired glucose tolerance (%)** | 17% |
Impaired fasting glucose defined as fasting plasma glucose between 100 and 125 mg/dL
Impaired glucose tolerance defined as two-hour plasma glucose during a 75g oral glucose tolerance test between 140 and 199 mg/dL